HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus.

AbstractBACKGROUND:
The potential use of microorganisms as agents of biological warfare (BW) is a growing concern. Lassa virus, a member of the Arenavirus class of Hemorrhagic fever (HF) viruses has emerged as a worldwide concern among public health officials. The purpose of the present study was to further elucidate the antiviral activity spectrum of stampidine, a novel nucleoside analog with potent anti-viral activity against the immunodeficiency viruses HIV-1, HIV-2, and FIV, by examining its effects on survival of mice challenged with Lassa virus.
METHODS:
We examined the therapeutic effect of Stampidine in CBA mice inoculated with intracerebral injections of the Josiah strain of Lassa virus. Mice were treated either with vehicle or nontoxic doses of stampidine administered intraperitoneally 24 hours prior to, 1 hour prior to, and 24 hours, 48 hours, 72 hours, and 96 hours after virus inoculation.
RESULTS:
The probability of survival following the Lassa challenge was significantly improved for stampidine treated mice (Kaplan Meier, Chi-squared = 11.7, df = 2, Log-Rank p-value = 0.003).
CONCLUSION:
Therefore, stampidine shows clinical potential as a new agent for treatment of viral hemorrhagic fevers caused by Lassa virus.
AuthorsFatih M Uckun, Alexander S Petkevich, Alexei O Vassilev, Heather E Tibbles, Leonid Titov
JournalBMC infectious diseases (BMC Infect Dis) Vol. 4 Pg. 1 (Jan 13 2004) ISSN: 1471-2334 [Electronic] England
PMID14720304 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Dideoxynucleotides
  • stampidine
  • Thymidine Monophosphate
  • Stavudine
Topics
  • Animals
  • Antiviral Agents (therapeutic use)
  • Dideoxynucleotides
  • Disease Models, Animal
  • Hemorrhagic Fevers, Viral (drug therapy, mortality)
  • Lassa virus
  • Mice
  • Mice, Inbred CBA
  • Stavudine (analogs & derivatives, therapeutic use)
  • Thymidine Monophosphate (analogs & derivatives, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: